FDA Requests Additional Information From Makers of Asthma Drugs for Children - DJ
More News related to AZN
- Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community
- New Expanded Atlantis(TM) Patient-Specific Abutment Compatibility and Material Option for Straumann Implants
- MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
- MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost
- Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018
More News related to GSK
- Piper Jaffray Downgrades Phase Forward (PFWD) to Neutral; Lack of Near-Term Catalysts
- Phase Forward (PFWD) Signs Multi-Yr, Multi-Million Dollar Contract with GlaxoSmithKline (GSK)
- Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018
- Society of Hispanic Professional Engineers Elects New National Board With Raytheon's Manny Hernandez as President
- Morning Movers 6/17: MERX, CYTR, SVNT, MIPI, TSTR Higher; ETFC, CTIC, AIB Lower
More News related to NVS
- Elan (ELN) Higher On Reports of Novartis Talks
- Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
- Video: New Biological Therapy Ilaris(R) Approved in US to Treat Children and Adults with CAPS, a Serious Life-Long Auto-Inflammatory Disease
- Novartis (NVS), Sanofi-Aventis (SNY), Glaxo (GSK) to Receive $661M of $1B Set Side for Developing H1N1 Flu Vaccine -CNBC
- Schering-Plough (SGP) Announces Changes to its Global Collaboration with Novartis (NVS)
Dow Jones reports the U.S. FDA said it's requested additional information from makers of certain asthma drugs as part of an ongoing safety review of the drugs in children.
The FDA will schedule another advisory panel later this year or early next year to evaluate any new information on the drugs, which include GlaxoSmithKline PLC's (NYSE: GSK) Serevent and Advair, Novartis AG's (NYSE: NVS) and Schering-Plough's (NYSE: SGP) Foradil and AstraZeneca's (NYSE: AZN) Symbicort.
GlaxoSmithKline plc (GSK) is a global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. [SM]
Related Categories
FDAStocks Mentioned
-17.22
+2.32Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
